BIIB vs TBRG · P/E 21, rev $9.89B vs P/E 90, rev $342.6M
Biogen Inc (BIIB) versus TruBridge Inc. (TBRG) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
TruBridge Inc. (TBRG) is a health information services company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported TBRG revenue for 2024-12-31 was $342.6M. Net income was -$20.4M. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. TBRG currently screens at market cap $391.6M and trailing P/E 90.0.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. TBRG currently screens at market cap $391.6M and trailing P/E 90.0.
Not investment advice. Open the BIIB and TBRG stock pages for the full models.
Not investment advice.